Related references
Note: Only part of the references are listed.Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
M. Haanpaa et al.
EUROPEAN JOURNAL OF PAIN (2016)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus
Miroslav 'Misha'' Backonja et al.
PAIN (2013)
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
Stephen Brown et al.
AIDS RESEARCH AND THERAPY (2013)
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
P. Anand et al.
BRITISH JOURNAL OF ANAESTHESIA (2011)
A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia
Gordon A. Irving et al.
PAIN MEDICINE (2011)
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes
C. Maier et al.
PAIN (2010)
NGX-4010, a high concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study (vol 7, pg 1106, 2008)
M. Backonja et al.
LANCET NEUROLOGY (2009)
The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy
J. Robinson Singleton et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
David M. Simpson et al.
NEUROLOGY (2008)
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
Miroslav Backonja et al.
LANCET NEUROLOGY (2008)
The impact of neuropathic pain on health-related quality of life - Review and implications
Mark P. Jensen et al.
NEUROLOGY (2007)
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy
Carolina M. Casellini et al.
DIABETES CARE (2007)
Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies
Aaron I. Vinik et al.
PAIN (2007)
The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes
Mark Davies et al.
DIABETES CARE (2006)
Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns
T Tolle et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy
KE Schmader
CLINICAL JOURNAL OF PAIN (2002)
Share Paper
